Meeting
2022 ASCO Annual Meeting
Prevalence of incidental pathogenic germline variants detected in cfDNA in patients with oncogene-driven non-small cell lung cancer.
Authors
Laura Mezquita
Hospital Clinic-DIBAPS, Barcelona, Spain
Laura Mezquita , Leslie A. Bucheit , Juan Carlos Laguna , Belen Pastor , Cristina Teixido , Teresa Gorria , Victor Albarran-Artahona , Marta Garcia de Herreros , Roxana Reyes , Noemi Reguart , Nuria Vinolas , Ainara Arcocha , Joan Anton Puig-Butillé , Leylah Drusbosky , Iris Faull , Elena Castro , Jyoti D. Patel , Aleix Prat , Benjamin Besse
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Prevention, Risk Reduction, and Hereditary Cancer
Track
Prevention, Risk Reduction, and Genetics
Sub Track
Etiology/Epidemiology
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr 10569)
DOI
10.1200/JCO.2022.40.16_suppl.10569
Abstract #
10569
Poster Bd #
445
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Circulating tumor DNA–based genomic landscape of KRAS wild-type pancreatic adenocarcinoma.
First Author: Brendon Fusco
Poster
2019 Gastrointestinal Cancers Symposium
Genomic alterations in appendiceal carcinoma using circulating DNA.
First Author: Walid Labib Shaib
Poster
2024 ASCO Annual Meeting
Characterization of diverse targetable ERBB2 alterations in 512,993 patients with solid tumors.
First Author: Dazhi Liu
Poster
2023 ASCO Annual Meeting
Prevalence of pathogenic germline variants in a cohort of patients with early onset non-small cell lung cancer (EOLUNG).
First Author: Maria Jove